**Recent health disclosures and legislative return have created a narrow balance around the slim trader consensus favoring completion of the term.** Rep. Tom Kean Jr. (R-NJ-7) returned to the House floor on June 30, 2026, after a four-month absence that began in early March, disclosing treatment for depression and expressing readiness to resume duties. He had advanced through the June 2 Republican primary and continues his re-election campaign in the competitive district against Democrat Rebecca Bennett, with the general election set for November 2026 and the current term concluding in January 2027. The prolonged prior absence, during which he missed over 100 votes, introduced uncertainty about sustained capacity to serve, yet his public return and active primary participation have supported the slight edge for remaining in office. Key variables that could shift the odds include recurrence of health challenges prompting resignation, developments in the fall campaign that alter his trajectory, or any unexpected personal or political developments before the term expires. Trader pricing reflects this equilibrium between recovery signals and residual questions about continuity.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วใหม่
ใหม่
Jan 3, 2027
ใหม่
ใหม่
Jan 3, 2027
This market will resolve to “Yes” if Thomas Kean Jr. ceases to be United States Representative from New Jersey's 7th congressional district for any period of time between market creation and the regularly scheduled end of his term in the current Congress. Otherwise, this market will resolve to “No”.
An announcement of Kean's early resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Thomas Kean Jr. and the U.S. government; however, a consensus of credible reporting may also be used.**Recent health disclosures and legislative return have created a narrow balance around the slim trader consensus favoring completion of the term.** Rep. Tom Kean Jr. (R-NJ-7) returned to the House floor on June 30, 2026, after a four-month absence that began in early March, disclosing treatment for depression and expressing readiness to resume duties. He had advanced through the June 2 Republican primary and continues his re-election campaign in the competitive district against Democrat Rebecca Bennett, with the general election set for November 2026 and the current term concluding in January 2027.
The prolonged prior absence, during which he missed over 100 votes, introduced uncertainty about sustained capacity to serve, yet his public return and active primary participation have supported the slight edge for remaining in office. Key variables that could shift the odds include recurrence of health challenges prompting resignation, developments in the fall campaign that alter his trajectory, or any unexpected personal or political developments before the term expires. Trader pricing reflects this equilibrium between recovery signals and residual questions about continuity.
This market will resolve to “Yes” if Thomas Kean Jr. ceases to be United States Representative from New Jersey's 7th congressional district for any period of time between market creation and the regularly scheduled end of his term in the current Congress. Otherwise, this market will resolve to “No”.
An announcement of Kean's early resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Thomas Kean Jr. and the U.S. government; however, a consensus of credible reporting may also be used.
An announcement of Kean's early resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Thomas Kean Jr. and the U.S. government; however, a consensus of credible reporting may also be used.
ตลาดเปิดเมื่อ: Jul 1, 2026, 5:02 PM ET
ปริมาณการซื้อขาย
$0วันสิ้นสุด
Jan 3, 2027ตลาดเปิดเมื่อ
Jul 1, 2026, 5:02 PM ETResolver
0x65070BE91...This market will resolve to “Yes” if Thomas Kean Jr. ceases to be United States Representative from New Jersey's 7th congressional district for any period of time between market creation and the regularly scheduled end of his term in the current Congress. Otherwise, this market will resolve to “No”.
An announcement of Kean's early resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Thomas Kean Jr. and the U.S. government; however, a consensus of credible reporting may also be used.**Recent health disclosures and legislative return have created a narrow balance around the slim trader consensus favoring completion of the term.** Rep. Tom Kean Jr. (R-NJ-7) returned to the House floor on June 30, 2026, after a four-month absence that began in early March, disclosing treatment for depression and expressing readiness to resume duties. He had advanced through the June 2 Republican primary and continues his re-election campaign in the competitive district against Democrat Rebecca Bennett, with the general election set for November 2026 and the current term concluding in January 2027.
The prolonged prior absence, during which he missed over 100 votes, introduced uncertainty about sustained capacity to serve, yet his public return and active primary participation have supported the slight edge for remaining in office. Key variables that could shift the odds include recurrence of health challenges prompting resignation, developments in the fall campaign that alter his trajectory, or any unexpected personal or political developments before the term expires. Trader pricing reflects this equilibrium between recovery signals and residual questions about continuity.
This market will resolve to “Yes” if Thomas Kean Jr. ceases to be United States Representative from New Jersey's 7th congressional district for any period of time between market creation and the regularly scheduled end of his term in the current Congress. Otherwise, this market will resolve to “No”.
An announcement of Kean's early resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Thomas Kean Jr. and the U.S. government; however, a consensus of credible reporting may also be used.
An announcement of Kean's early resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Thomas Kean Jr. and the U.S. government; however, a consensus of credible reporting may also be used.
ปริมาณการซื้อขาย
$0วันสิ้นสุด
Jan 3, 2027ตลาดเปิดเมื่อ
Jul 1, 2026, 5:02 PM ETResolver
0x65070BE91...**Recent health disclosures and legislative return have created a narrow balance around the slim trader consensus favoring completion of the term.** Rep. Tom Kean Jr. (R-NJ-7) returned to the House floor on June 30, 2026, after a four-month absence that began in early March, disclosing treatment for depression and expressing readiness to resume duties. He had advanced through the June 2 Republican primary and continues his re-election campaign in the competitive district against Democrat Rebecca Bennett, with the general election set for November 2026 and the current term concluding in January 2027. The prolonged prior absence, during which he missed over 100 votes, introduced uncertainty about sustained capacity to serve, yet his public return and active primary participation have supported the slight edge for remaining in office. Key variables that could shift the odds include recurrence of health challenges prompting resignation, developments in the fall campaign that alter his trajectory, or any unexpected personal or political developments before the term expires. Trader pricing reflects this equilibrium between recovery signals and residual questions about continuity.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย